Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD
Authors
Keywords
-
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-02
DOI
10.1007/s40618-020-01188-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
- (2019) Javier Ampuero et al. Clinical Gastroenterology and Hepatology
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
- (2018) Laura Pimpin et al. JOURNAL OF HEPATOLOGY
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity
- (2016) Pierre Bedossa et al. GUT
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies
- (2016) L. Li et al. Obesity Reviews
- Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese
- (2016) Geraldine J. Ooi et al. OBESITY SURGERY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery
- (2015) Shinhiti Morita et al. OBESITY SURGERY
- The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial
- (2015) P. Praveen Raj et al. Surgery for Obesity and Related Diseases
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Effects of coffee, smoking, and alcohol on liver function tests: a comprehensive cross-sectional study
- (2012) Eun Sun Jang et al. BMC GASTROENTEROLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
- (2009) Anna Kotronen et al. GASTROENTEROLOGY
- The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD
- (2008) Kamran Qureshi et al. OBESITY SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now